Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.7 (
DNA polymerase
)
17,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sucrose density gradient analysis of Neurospora cell free extract showed at least three distinct peaks of enzyme activity; of these, a high molecular weight enzyme was identified as
DNA polymerase alpha
because of its sensitivity to aphidicolin and to NEM.
DNA polymerase
mutants of Neurospora crassa were isolated by their resistance to aphidicolin, a specific inhibitor of the eukaryotic
DNA polymerase alpha
. Some mutants showed an increase in the specific activity of the enzyme. One mutant (
E-2
-4-1) characterized in detail showed the presence of
DNA polymerase
which was resistant to inhibitory action of aphidicolin in an in vitro assay. Another mutant (C-3) showed changes in the pH optimum of the enzyme activity. Genetic characterization of the mutants provided evidence for the dominance of the aphr allele controlling aphidicolin resistance and its Mendelian segregation. Some of the aphidicolin resistant mutants were found to be UV-sensitive. Neurospora wild-type and mutant genomic DNA digest was found to hybridize with a cloned yeast
DNA polymerase
gene. The nick translated yeast
DNA polymerase
gene was used to screen a genomic cosmid library of Neurospora. A putative clone containing Neurospora
DNA polymerase
gene has been identified. Further molecular characterization of the Neurospora
DNA polymerase
gene and enzyme is in progress.
...
PMID:Characterization of eukaryotic DNA polymerases: aphidicolin resistant mutants of Neurospora with altered DNA polymerase. 214 49